Literature DB >> 7782435

Hydrosalpinges in in-vitro fertilization: an unfavourable prognostic feature.

J Vandromme1, E Chasse, B Lejeune, M Van Rysselberge, A Delvigne, F Leroy.   

Abstract

The aim of this study was to determine whether the presence of a hydrosalpinx influences in-vitro fertilization (IVF) prognosis. Comparisons were made between 69 IVF cycles in 37 patients carrying hydrosalpinges (hydrosalpinx group) and 67 IVF cycles in 41 patients without tubes or surgically sterilized (control group). Twenty-two patients carrying hydrosalpinges underwent salpingectomy or salpingoplasty (operated group); they then underwent 42 IVF trials which were compared with the two former groups. In the hydrosalpinx group, pregnancy rates by oocyte retrieval were 10.1% for clinical and ongoing pregnancies. In the control group, the corresponding pregnancy rates were 23.0 and 21.3% respectively. The implantation rate per embryo was 4.2% for clinical and ongoing pregnancies in the hydrosalpinx group and 11.0 and 10.4% respectively in the control group. The operated group had pregnancy rates of 38.1% for clinical pregnancies and 31.0% for ongoing pregnancies, with implantation rates of 17.4 (clinical) and 14.8% (ongoing) respectively. Pregnancy and implantation rates were statistically lower in the hydrosalpinx group as compared with controls and with the operated group. The differences between control and operated groups were not significant. In conclusion, the presence of a hydrosalpinx is thus associated with poor prognosis in IVF treatment. Surgical correction of such lesions appears to restore high success rates.

Entities:  

Mesh:

Year:  1995        PMID: 7782435     DOI: 10.1093/oxfordjournals.humrep.a135992

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  19 in total

1.  The effect of hydrosalpinges on IVF-ET outcome.

Authors:  L I Barmat; E Rauch; S Spandorfer; A Kowalik; E S Sills; G Schattman; H C Liu; Z Rosenwaks
Journal:  J Assist Reprod Genet       Date:  1999-08       Impact factor: 3.412

2.  Controlled ovarian hyperstimulation adversely affects implantation following in vitro fertilization-embryo transfer.

Authors:  J H Check; J K Choe; D Katsoff; D Summers-Chase; C Wilson
Journal:  J Assist Reprod Genet       Date:  1999-09       Impact factor: 3.412

3.  How members of the Society for Reproductive Endocrinology and Infertility and Society of Reproductive Surgeons evaluate, define, and manage hydrosalpinges.

Authors:  Kenan Omurtag; Natalia M Grindler; Kimberly A Roehl; Gordon Wright Bates; Angeline N Beltsos; Randall R Odem; Emily S Jungheim
Journal:  Fertil Steril       Date:  2012-03-09       Impact factor: 7.329

Review 4.  Mild ovarian stimulation.

Authors:  Jerome H Check
Journal:  J Assist Reprod Genet       Date:  2007-12-04       Impact factor: 3.412

Review 5.  Uterus transplantation: From animal models through the first heart beating pregnancy to the first human live birth.

Authors:  Omer Ozkan; Nasuh Utku Dogan; Ozlenen Ozkan; Inanc Mendilcioglu; Selen Dogan; Batu Aydinuraz; Mehmet Simsek
Journal:  Womens Health (Lond)       Date:  2016-07

Review 6.  Local and systemic factors and implantation: what is the evidence?

Authors:  Chelsea Fox; Scott Morin; Jae-Wook Jeong; Richard T Scott; Bruce A Lessey
Journal:  Fertil Steril       Date:  2016-03-03       Impact factor: 7.329

7.  Salpingectomy for repeated embryo nonimplantation after in vitro fertilization in patients with severe tubal factor infertility.

Authors:  H Dechaud; T Anahory; N Aligier; F Arnal; H Humeau; B Hedon
Journal:  J Assist Reprod Genet       Date:  2000-04       Impact factor: 3.412

8.  The presence of hydrosalpinx may not adversely affect the implantation and pregnancy rates in in vitro fertilization treatment.

Authors:  E H Ng; W S Yeung; P C Ho
Journal:  J Assist Reprod Genet       Date:  1997-10       Impact factor: 3.412

9.  State-mandated insurance coverage is associated with the approach to hydrosalpinges before IVF.

Authors:  Kenan Omurtag; Natalia M Grindler; Kimberly A Roehl; G Wright Bates; Angeline N Beltsos; Randall R Odem; Emily S Jungheim
Journal:  Reprod Biomed Online       Date:  2014-03-24       Impact factor: 3.828

Review 10.  Surgical treatment for tubal disease in women due to undergo in vitro fertilisation.

Authors:  Neil Johnson; Sabine van Voorst; Martin C Sowter; Annika Strandell; Ben Willem J Mol
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.